Pub. Date : 2013 Jun 28
PMID : 23726915
15 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Intracellular NAADP increase induced by extracellular NAADP via the P2Y11-like receptor. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 2 | Intracellular NAADP increase induced by extracellular NAADP via the P2Y11-like receptor. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 3 | The aim of the study was to identify a signalling pathway allowing NAADP-induced intracellular NAADP increase and involving the P2Y11-like receptor. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 4 | The aim of the study was to identify a signalling pathway allowing NAADP-induced intracellular NAADP increase and involving the P2Y11-like receptor. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 5 | Using a Langendorff model we report a positive inotropic response induced by extracellular NAADP via P2Y11-like receptor stimulation. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 6 | In cardiomyocyte cultures, P2Y11-like receptor stimulation by extracellular NAADP ([NAADP]e) increased intracellular cADP-ribose and NAADP concentration as evidenced by direct measurements. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 7 | In cardiomyocyte cultures, P2Y11-like receptor stimulation by extracellular NAADP ([NAADP]e) increased intracellular cADP-ribose and NAADP concentration as evidenced by direct measurements. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 8 | In cardiomyocyte cultures, P2Y11-like receptor stimulation by extracellular NAADP ([NAADP]e) increased intracellular cADP-ribose and NAADP concentration as evidenced by direct measurements. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 9 | NF546, a new selective P2Y11 receptor agonist, increased intracellular cAMP, cADP-ribose and NAADP concentration confirming the involvement of the P2Y11-like receptor in this signalling pathway. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 10 | NF157, a P2Y11 receptor antagonist, suppressed the increase in intracellular cADPr, NAADP and NAAD induced by either [NAADP]e or NF546. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 11 | NF157, a P2Y11 receptor antagonist, suppressed the increase in intracellular cADPr, NAADP and NAAD induced by either [NAADP]e or NF546. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 12 | The response profile for intracellular cADP-ribose and NAADP concentration following P2Y11-like stimulation with NF546 was similar to reported data relating beta-adrenergic stimulation with isoprenaline. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 13 | Moreover, this study provides a signalling pathway: intracellular NAADP increase induced by extracellular NAADP via metabotropic activity of P2Y11-like receptor. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 14 | Moreover, this study provides a signalling pathway: intracellular NAADP increase induced by extracellular NAADP via metabotropic activity of P2Y11-like receptor. | NAADP | purinergic receptor P2Y11 | Homo sapiens |
| 15 | This pathway implying P2Y11-like could take part in the intracellular calcium rise reported for extracellular NAADP. | NAADP | purinergic receptor P2Y11 | Homo sapiens |